title: Letter: proton pump inhibitor usage still seems to reduce the risk of high-grade dysplasia and/or oesophageal adenocarcinoma in Barrett's oesophagus.
authors.affiliation: Department of Gastroenterology - Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey. yucel.aydin@marmara.edu.tr.
authors.forename: Y
authors.initials: Y
authors.lastname: Aydin
authors.forename: H
authors.initials: H
authors.lastname: Akin
mesh_terms: D000230:Adenocarcinoma / Q000517:prevention & control*; D001471:Barrett Esophagus / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000517:prevention & control*; D004947:Esophagus / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*
chemical_list: D054328:Proton Pump Inhibitors